Allianz Asset Management’s Crinetics Pharmaceuticals CRNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-16,400
| Closed | -$839K | – | 1741 |
|
|
2024
Q4 | $839K | Buy |
16,400
+2,200
| +15% | +$112K | ﹤0.01% | 1272 |
|
|
2024
Q3 | $726K | Buy |
14,200
+6,300
| +80% | +$322K | ﹤0.01% | 1323 |
|
|
2024
Q2 | $354K | Buy |
7,900
+3,000
| +61% | +$134K | ﹤0.01% | 1487 |
|
|
2024
Q1 | $229K | Sell |
4,900
-7,800
| -61% | -$365K | ﹤0.01% | 1583 |
|
|
2023
Q4 | $452K | Buy |
+12,700
| New | +$452K | ﹤0.01% | 1437 |
|